Registration
FOLEY & LARDNER LLP for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY
Firm
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER FITZGERALD WALSH New | Administrative Assistant, Deputy COS, COS: Rep. Dennis Cardoza; Field Representative: Rep. Vic Fazio; Staff Assistant, Program Director, Executive Assistant: House Democratic Caucus |
Health Issues HCR
FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER FITZGERALD WALSH New | Administrative Assistant, Deputy COS, COS: Rep. Dennis Cardoza; Field Representative: Rep. Vic Fazio; Staff Assistant, Program Director, Executive Assistant: House Democratic Caucus |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ENDO INTERNATIONAL PLC | Ireland | Ireland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.